(19)
(11) EP 2 102 341 A2

(12)

(88) Date of publication A3:
11.12.2008

(43) Date of publication:
23.09.2009 Bulletin 2009/39

(21) Application number: 07871694.1

(22) Date of filing: 10.12.2007
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
(86) International application number:
PCT/US2007/087038
(87) International publication number:
WO 2008/073923 (19.06.2008 Gazette 2008/25)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 08.12.2006 US 869295 P
29.12.2006 US 882758 P

(71) Applicants:
  • Asuragen, INC.
    Austin, TX 78744 (US)
  • Yale University, Inc.
    New Haven CT 06510 (US)

(72) Inventors:
  • BYROM, Mike
    Austin, TX 78744 (US)
  • JOHNSON, Charles D.
    Austin, TX 78744 (US)
  • BROWN, David
    Austin, TX 78744 (US)
  • BADER, Andreas G.
    Austin, TX 78744 (US)

(74) Representative: Sonn & Partner Patentanwälte 
Riemergasse 14
1010 Wien
1010 Wien (AT)

   


(54) MIRNA REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION